Lauren Dembeck, PhD

Contributing Writer https://www.infectiousdiseaseadvisor.com

Lauren Dembeck is a freelance science and medical writer and a contributing author for the Haymarket Medical Network. She holds a BS in biology and a BA in foreign languages from West Virginia University and a PhD in genetics from North Carolina State University. Prior to freelance writing, Lauren was a postdoctoral researcher at the Okinawa Institute of Science and Technology in Japan, where she studied developmental neurobiology. You can find more of her writing at https://laurendembeck.com/.

All articles by Lauren Dembeck, PhD

COVID19

Use of Empiric Therapeutic Anticoagulation in Critically Ill Patients With COVID-19

Lauren Dembeck, PhD

January 6, 2021

Researchers evaluated coagulation-linked complications in critically ill patients with COVID-19 and survival outcomes following therapeutic anticoagulation.

COVID19

Use of Convalescent Plasma Therapy in Severe COVID-19 in the Yale-New Haven Health System

Lauren Dembeck, PhD

January 4, 2021

A multicenter team reported on the administration of COVID-19 convalescent plasma to patients with severe COVID-19 in the Yale-New Haven Health System.

Whether cryosurgery or cryoablation will prove a viable alternative to lumpectomy — the standard of

COVID19

COVID-19–Free Surgical Pathways Benefit Patients Undergoing Elective Cancer Surgery

Lauren Dembeck, PhD

October 28, 2020

Elective cancer surgery within COVID-19–free surgical pathways results in lower pulmonary complication, SARS-CoV-2 infection, and mortality rates.

COVID19

Factor V Activity Associated With Clinical Outcomes in Severe COVID-19

Lauren Dembeck, PhD

September 15, 2020

Investigators assess underlying mechanisms and relevant biomarkers of morbidity and mortality due to coagulopathy in patients with severe COVID-19 infection.

Pediatric Illnesses

Risk-Adapted Therapy Prevents Fungal Infections in Childhood Leukemia

Lauren Dembeck, PhD

July 21, 2020

Risk-adapted therapy effectively prevents fungal infections and reduces neurotoxicity in children with leukemia.

GI Illness

Decreasing Prevalence of H pylori and Associated Gastric and Duodenal Ulcers

Lauren Dembeck, PhD

March 17, 2020

The prevalence of H pylori infection continues to fall in the general population with only 16% of all gastric and 25% of all duodenal patients with ulcer harboring H pylori.

GI Illness

Changes in Gut Microbiome Associated With Biologic Therapy in Inflammatory Bowel Disease

Lauren Dembeck, PhD

December 10, 2019

Prospective studies are needed to determine what changes are significantly associated with treatment, whether these changes are causes or effects of response, and whether the composition of the intestinal microbiome can be used to select treatments for patients with IBD.

Illustration of a viral infection in the bloodstream.

Respiratory

Outcomes After Delaying Hematopoietic Stem Cell Transplantation in Children With Viral Respiratory Infections

Lauren Dembeck, PhD

November 1, 2019

Patients with viral respiratory infections exhibited poorer outcomes following transplantation compared with patients without infection.

Next post in Respiratory